Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Role of cholesterol in Mycobacterium tuberculosis infection.

Miner MD, Chang JC, Pandey AK, Sassetti CM, Sherman DR.

Indian J Exp Biol. 2009 Jun;47(6):407-11. Review.

PMID:
19634704
2.

Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.

Ouellet H, Johnston JB, de Montellano PR.

Trends Microbiol. 2011 Nov;19(11):530-9. doi: 10.1016/j.tim.2011.07.009. Review.

3.

Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis.

Wipperman MF, Sampson NS, Thomas ST.

Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):269-93. doi: 10.3109/10409238.2014.895700. Review.

4.

Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.

Bailo R, Bhatt A, Aínsa JA.

Biochem Pharmacol. 2015 Aug 1;96(3):159-67. doi: 10.1016/j.bcp.2015.05.001. Review.

PMID:
25986884
5.

Extra and intracellular expression of Mycobacterium tuberculosis genes.

Smith I, Dussurget O, Rodriguez GM, Timm J, Gomez M, Dubnau J, Gold B, Manganelli R.

Tuber Lung Dis. 1998;79(2):91-7. Review.

PMID:
10645446
6.

PhoP, a key player in Mycobacterium tuberculosis virulence.

Ryndak M, Wang S, Smith I.

Trends Microbiol. 2008 Nov;16(11):528-34. doi: 10.1016/j.tim.2008.08.006. Review.

PMID:
18835713
7.

Mycobacterial genes essential for the pathogen's survival in the host.

Ehrt S, Rhee K, Schnappinger D.

Immunol Rev. 2015 Mar;264(1):319-26. doi: 10.1111/imr.12256. Review.

8.

Game of 'Somes: Protein Destruction for Mycobacterium tuberculosis Pathogenesis.

Samanovic MI, Darwin KH.

Trends Microbiol. 2016 Jan;24(1):26-34. doi: 10.1016/j.tim.2015.10.001. Review.

9.

Hypoxia: a window into Mycobacterium tuberculosis latency.

Rustad TR, Sherrid AM, Minch KJ, Sherman DR.

Cell Microbiol. 2009 Aug;11(8):1151-9. doi: 10.1111/j.1462-5822.2009.01325.x. Review.

PMID:
19388905
10.

Multiple moonlighting functions of mycobacterial molecular chaperones.

Henderson B, Lund PA, Coates AR.

Tuberculosis (Edinb). 2010 Mar;90(2):119-24. doi: 10.1016/j.tube.2010.01.004. Review.

PMID:
20338810
11.

Redox homeostasis in mycobacteria: the key to tuberculosis control?

Kumar A, Farhana A, Guidry L, Saini V, Hondalus M, Steyn AJ.

Expert Rev Mol Med. 2011 Dec 16;13:e39. doi: 10.1017/S1462399411002079. Review.

12.

Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Abuhammad A.

Br J Pharmacol. 2016 Dec 21. doi: 10.1111/bph.13694. [Epub ahead of print] Review.

PMID:
28002883
13.

"Genetic regulation of Mycobacterium tuberculosis in a lipid-rich environment".

Aguilar-Ayala DA, Palomino JC, Vandamme P, Martin A, Gonzalez-Y-Merchand JA.

Infect Genet Evol. 2016 Oct 19. pii: S1567-1348(16)30424-5. doi: 10.1016/j.meegid.2016.10.015. [Epub ahead of print] Review.

PMID:
27771519
14.

Catabolism and biotechnological applications of cholesterol degrading bacteria.

García JL, Uhía I, Galán B.

Microb Biotechnol. 2012 Nov;5(6):679-99. doi: 10.1111/j.1751-7915.2012.00331.x. Review.

Items per page

Supplemental Content

Support Center